Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02751983 · ClinicalTrials.gov registry record · NA
ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT02751983: Completed NA study, sponsored by VA Office of Research and Development.
NCT02751983 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02751983, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
An estimated 20 Veterans kill themselves every day. Suicide prevention literature and public health policy both call for treatment targeting high-risk populations, such as Veterans hospitalized due to suicidal intent and/or attempts. Psychiatric hospitalization is a critical opportunity to provide treatment to reduce the risk of suicide and lay the groundwork for functional recovery. Yet, there are no interventions specifically for suicide prevention that meet Veterans Health Affairs' quality recommendations requiring the provision of evidence-based, recovery-oriented psychotherapy, which are also feasible to use during a typical inpatient stay. The proposed study seeks to take a first step toward filling this gap. In consultation with experts in the field, the authors have developed a protocol applying a recovery-oriented, evidence-based treatment approach to Veteran inpatient care. The proposed pilot study will provide critical information to inform final revisions of the treatment manual and research design for a future study evaluating the efficacy of the intervention.
Interventions
- OTHER Treatment as usual
- BEHAVIORAL ACT for Life
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02751983
The ClinicalTrials.gov registry entry for NCT02751983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.
NCT02751983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02751983 about?
NCT02751983 is a clinical study titled "ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises". An estimated 20 Veterans kill themselves every day. Suicide prevention literature and public health policy both call for treatment targeting high-risk populations, such as Veterans hospitalized due to suicidal intent and/or attempts. Psychiatric hospitalization is a critical opportunity to provide t...
What is the current status of trial NCT02751983?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2016-11-15. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02751983?
The interventions under investigation include: Treatment as usual (OTHER), ACT for Life (BEHAVIORAL).
Who is sponsoring clinical trial NCT02751983?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.